“Aim of this blog is to provide latest information and health links to Allied Healthcare professionals and to encourage information sharing across the globe".
Tuesday, 11 October 2011
Saturday, 8 October 2011
Neural Linkage Between Motivation And Motor Functional Recovery Through Rehabilitative Training
An effective recovery has been observed instroke patients and those with spinal cord injuries who have strong vitality and motivation to rehabilitate in clinical practice. However, it was not really clear how motivation facilitates functional recovery in brain science. The joint research team consisting of Associate Professor Yukio NISHIMURA, and Professor Tadashi ISA from the National Institute for Physiological Sciences, Dr. Hirotaka ONOE, Team Leader in the Functional Probe Research Laboratory of RIKEN, the Center for Molecular Imaging Science, and also Dr. Hideo TSUKADA, Manager of PET Center, Hamamatsu Photonics K.K., Central Research Laboratory, revealed that the more motor function recovery progresses, the stronger the functional connectivity between the brain which regulates motivation, and in the brain regions involved in the motor learning and functional recovery. This occurs through rehabilitative training of macaque monkeys after the spinal cord injuries. The result of this study suggests that the functional recovery of motor system for a patient with damage to the central nervous system can be advanced effectively, by activating the brain region which controls "motivation". The result of this study was reported in PLoS ONE, an American science magazine (September 28, 2011 electronic edition).
Source:http://www.medicalnewstoday.com/releases/235206.php
Source:http://www.medicalnewstoday.com/releases/235206.php
Labels:
OT mental health
Monday, 3 October 2011
Extending Life Of Arthritic Joints
A medication already approved to build bone mass in patients with osteoporosis also builds cartilage around joints and could potentially be repurposed to treat millions of people suffering from arthritis, according to orthopaedic research at the University of Rochester Medical Center.
The study authors hope their laboratory findings, published in the current issue ofScience Translational Medicine, will set the stage for the first human clinical trials to test human parathyroid hormone (brand name:Forteo) in this growing patient population.
Since 2005, arthritis has been ranked as the leading cause of disability in the United States by the Centers for Disease Control and Prevention. And by 2030 an estimated 67 million people, or 25 percent of the adult population in this country will have osteoarthritis (OA), a painful, degenerative joint disease that often begins with an injury and results in the progressive loss of cartilage. Current treatments for OA do not help improve the cartilage in the diseased joint, they only make the pain more bearable. Examples include oral anti-inflammatory agents (such as Advil or Naproxen), narcotics, or steroid injections into the affected joint. Surgical replacement of the joint and cartilage is usually required, although this major intervention often carries its own set of complications.
Link:http://www.medicalnewstoday.com/releases/234826.php
The study authors hope their laboratory findings, published in the current issue ofScience Translational Medicine, will set the stage for the first human clinical trials to test human parathyroid hormone (brand name:Forteo) in this growing patient population.
Since 2005, arthritis has been ranked as the leading cause of disability in the United States by the Centers for Disease Control and Prevention. And by 2030 an estimated 67 million people, or 25 percent of the adult population in this country will have osteoarthritis (OA), a painful, degenerative joint disease that often begins with an injury and results in the progressive loss of cartilage. Current treatments for OA do not help improve the cartilage in the diseased joint, they only make the pain more bearable. Examples include oral anti-inflammatory agents (such as Advil or Naproxen), narcotics, or steroid injections into the affected joint. Surgical replacement of the joint and cartilage is usually required, although this major intervention often carries its own set of complications.
Link:http://www.medicalnewstoday.com/releases/234826.php
Labels:
osteoporosis
Sunday, 2 October 2011
Neural Linkage Between Motivation And Motor Functional Recovery Through Rehabilitative Training
An effective recovery has been observed instroke patients and those with spinal cord injuries who have strong vitality and motivation to rehabilitate in clinical practice. However, it was not really clear how motivation facilitates functional recovery in brain science. The joint research team consisting of Associate Professor Yukio NISHIMURA, and Professor Tadashi ISA from the National Institute for Physiological Sciences, Dr. Hirotaka ONOE, Team Leader in the Functional Probe Research Laboratory of RIKEN, the Center for Molecular Imaging Science, and also Dr. Hideo TSUKADA, Manager of PET Center, Hamamatsu Photonics K.K., Central Research Laboratory, revealed that the more motor function recovery progresses, the stronger the functional connectivity between the brain which regulates motivation, and in the brain regions involved in the motor learning and functional recovery. This occurs through rehabilitative training of macaque monkeys after the spinal cord injuries. The result of this study suggests that the functional recovery of motor system for a patient with damage to the central nervous system can be advanced effectively, by activating the brain region which controls "motivation". The result of this study was reported in PLoS ONE, an American science magazine (September 28, 2011 electronic edition).
Link:http://www.medicalnewstoday.com/releases/235206.php
Link:http://www.medicalnewstoday.com/releases/235206.php
Labels:
Brain and Body
Friday, 30 September 2011
Yoga Reduces The Physical And Psychological Symptoms Of Chronic Pain In Women With Fibromyalgia
The study is the first to look at the effects of yoga on cortisol levels in women withfibromyalgia. The condition, which predominantly affects women, is characterized by chronic pain and fatigue; common symptoms include muscle stiffness, sleep disturbances, gastrointestinal discomfort, anxiety and depression.
Previous research has found that women with fibromyalgia have lower-than-average cortisol levels, which contribute to pain,fatigue and stress sensitivity. According to the study, participants' saliva revealed elevated levels of total cortisol following a program of 75 minutes of hatha yoga twice weekly over the course of eight weeks.
"Ideally, our cortisol levels peak about 30-40 minutes after we get up in the morning and decline throughout the day until we're ready to go to sleep," says the study's lead author, Kathryn Curtis, a PhD student in York's Department of Psychology, Faculty of Health. "The secretion of the hormone, cortisol, is dysregulated in women with fibromyalgia" she says.
Link:http://www.medicalnewstoday.com/releases/231970.php
Previous research has found that women with fibromyalgia have lower-than-average cortisol levels, which contribute to pain,fatigue and stress sensitivity. According to the study, participants' saliva revealed elevated levels of total cortisol following a program of 75 minutes of hatha yoga twice weekly over the course of eight weeks.
"Ideally, our cortisol levels peak about 30-40 minutes after we get up in the morning and decline throughout the day until we're ready to go to sleep," says the study's lead author, Kathryn Curtis, a PhD student in York's Department of Psychology, Faculty of Health. "The secretion of the hormone, cortisol, is dysregulated in women with fibromyalgia" she says.
Link:http://www.medicalnewstoday.com/releases/231970.php
Labels:
Pain
Wednesday, 28 September 2011
Back Pain Recovery Time Unclear, Causing Many Problems To Become Chronic
According to professionals at the 7th EFIC Congress - Pain in Europe VII Hamburg, the prognosis for unspecific back pain which is already an epidemic in industrialized countries, has been worse than commonly recognized. This pain, which cannot be linked to any specific disease, needs further research and rehabilitation efforts if treatment methods are to be increased and enhanced. There is some hope that such efforts may develop.
(EFIC stands for European Federation of IASP® Chapters. A multidisciplinary professional organization in the field of pain research and medicine.)
Link:http://www.medicalnewstoday.com/articles/235011.php
(EFIC stands for European Federation of IASP® Chapters. A multidisciplinary professional organization in the field of pain research and medicine.)
Link:http://www.medicalnewstoday.com/articles/235011.php
Labels:
Back Pain
Cardiac Rehabilitation Improves Heart Rate Recovery, Boosts Survival
For the first time, researchers have discovered cardiac rehabilitation can train the heart to quickly return to its normal rate after exercise.
In a study reported in Circulation: Journal of the American Heart Association, researchers said heart disease patients with normal heart rate recovery live longer than those with slow heart rate recovery. A heart that returns to normal rate more quickly works better than one that stays revved up for a while.
"There's no medicine that can do that," said Leslie Cho, M.D., lead author of the study and director of the Women's Cardiovascular Center at the Cleveland Clinic in Ohio. "Especially in terms of mortality, if we had a medicine that could make this dramatic an impact, it would be the blockbuster drug of the century."
Link:
http://www.medicalnewstoday.com/releases/235038.php
In a study reported in Circulation: Journal of the American Heart Association, researchers said heart disease patients with normal heart rate recovery live longer than those with slow heart rate recovery. A heart that returns to normal rate more quickly works better than one that stays revved up for a while.
"There's no medicine that can do that," said Leslie Cho, M.D., lead author of the study and director of the Women's Cardiovascular Center at the Cleveland Clinic in Ohio. "Especially in terms of mortality, if we had a medicine that could make this dramatic an impact, it would be the blockbuster drug of the century."
Link:
http://www.medicalnewstoday.com/releases/235038.php
Labels:
Heart
Subscribe to:
Posts (Atom)